These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 4092059

  • 1. Hydrodynamic characterizations of estrogen receptors complexed with [3H]-4-hydroxytamoxifen: evidence in support of contrasting receptor transitions mediated by different ligands.
    Pavlik EJ, Nelson K, van Nagell JR, Donaldson ES, Walden ML, Hanson MB, Gallion H, Flanigan RC, Kenady DE.
    Biochemistry; 1985 Dec 31; 24(27):8101-6. PubMed ID: 4092059
    [Abstract] [Full Text] [Related]

  • 2. Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.
    Pavlik EJ, van Nagell JR, Nelson K, Gallion H, Donaldson ES, Kenady DE, Baranowska-Kortylewicz J.
    Endocrinology; 1986 May 31; 118(5):1924-34. PubMed ID: 2422013
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA, Lippman ME, Katzenellenbogen BS.
    Cancer Res; 1984 Nov 31; 44(11):5038-45. PubMed ID: 6488162
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B, Happe HK.
    Endocrinology; 1986 Aug 31; 119(2):904-15. PubMed ID: 3732150
    [Abstract] [Full Text] [Related]

  • 6. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
    Keene JL, Ruh MF, Ruh TS.
    J Steroid Biochem; 1984 Dec 31; 21(6):625-31. PubMed ID: 6527530
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of the estrogen receptor interaction with 4-hydroxytamoxifen.
    Sasson S, Notides AC.
    Mol Endocrinol; 1988 Apr 31; 2(4):307-12. PubMed ID: 3380103
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterisation of non-activated and activated estrogen- and antiestrogen-receptor complexes by high performance ion exchange chromatography.
    Myatt L, Wittliff JL.
    J Steroid Biochem; 1986 May 31; 24(5):1041-8. PubMed ID: 3724142
    [Abstract] [Full Text] [Related]

  • 10. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
    Borgna JL, Scali J.
    J Steroid Biochem; 1988 Oct 31; 31(4A):427-36. PubMed ID: 3050278
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor.
    Tate AC, Greene GL, DeSombre ER, Jensen EV, Jordan VC.
    Cancer Res; 1984 Mar 31; 44(3):1012-8. PubMed ID: 6692388
    [Abstract] [Full Text] [Related]

  • 13. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
    Borgna JL, Scali J.
    Eur J Biochem; 1991 Aug 01; 199(3):575-85. PubMed ID: 1868844
    [Abstract] [Full Text] [Related]

  • 14. Antiestrogen pharmacology and mechanism of action.
    Katzenellenbogen BS, Miller MA, Eckert RL, Sudo K.
    J Steroid Biochem; 1983 Jul 01; 19(1A):59-68. PubMed ID: 6887873
    [Abstract] [Full Text] [Related]

  • 15. High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite.
    Borgna JL, Rochefort H.
    Mol Cell Endocrinol; 1980 Oct 01; 20(1):71-85. PubMed ID: 7439523
    [Abstract] [Full Text] [Related]

  • 16. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus.
    Garcia M, Greene G, Rochefort H, Jensen EV.
    Endocrinology; 1982 Apr 01; 110(4):1355-61. PubMed ID: 7060530
    [Abstract] [Full Text] [Related]

  • 17. Immunological differences between the estradiol-, tamoxifen- and 4-hydroxy-tamoxifen-estrogen receptor complexes detected by two monoclonal antibodies.
    Giambiagi N, Pasqualini JR.
    J Steroid Biochem; 1988 Apr 01; 30(1-6):213-7. PubMed ID: 3386244
    [Abstract] [Full Text] [Related]

  • 18. Effects of sulfhydryl reagents on uterine nuclear estrogen receptors labeled by in vitro exchange with [3H]estradiol or [3H]4-hydroxytamoxifen.
    Attardi B.
    J Recept Res; 1984 Apr 01; 4(7):787-800. PubMed ID: 6527361
    [Abstract] [Full Text] [Related]

  • 19. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA.
    Klinge CM, Traish AM, Bambara RA, Hilf R.
    J Steroid Biochem Mol Biol; 1996 Jan 01; 57(1-2):51-66. PubMed ID: 8645617
    [Abstract] [Full Text] [Related]

  • 20. Estrogen and antiestrogen binding to different forms of the molybdate-stabilized estrogen receptor.
    Ruh MF, Brzyski RG, Strange L, Ruh TS.
    Endocrinology; 1983 Jun 01; 112(6):2203-5. PubMed ID: 6851947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.